0625/26SCR019-18/R12RGB
Media Highlights
From the 2026 ASCO® Annual Meeting
2
Mark Fleming, MD
SCRI at Virginia Oncology Associates I The US Oncology Network
Media Outlet Date Article / Coverage
Urology Times 5/30/26 Mark Fleming, MD, and Manojkumar Bupathi, MD, Discuss
the Most Anticipated GU Data at ASCO 2026
Peter Forsberg, MD
SCRI at Colorado Blood Cancer Institute
Media Outlet Date Article / Coverage
AJMC 6/1/26 Results Show Giving Prophylactic Tocilizumab Reduces CRS
in Outpatient Delivery of Teclistamab, Talquetamab
Cancer Network 5/31/26 Tocilizumab Supports Outpatient Bispecific Antibody Use in
Multiple Myeloma
Clinical Trials Arena 6/1/26 ASCO26: BMS and J&J Debut Shining Multiple Myeloma
Data
Oncology Learning
Network
6/19/26 Feasibility of Community-Based Outpatient Bispecific
Therapy in Multiple Myeloma
Benjamin Garmezy, MD
SCRI
Media Outlet Date Article / Coverage
Cancer Network 6/2/26 HC-7366 Plus Belzutifan Shows Favorable PK/PD Profile in
Advanced ccRCC
Cancer Network 6/11/26 ASCO 2026: Translating the Top Prostate Cancer Data Into
Clinical Action
Cancer Network 6/25/26 ASCO 2026: Practice-Guiding Updates in Bladder and
Kidney Cancer
Continued ➔
